- Stocks
- Healthcare
- NASDAQ: HQY

Price (delayed)

$64.06

Market cap

$5.35B

P/E Ratio

6,406

Dividend/share

N/A

EPS

$0.01

Enterprise value

$5.65B

HealthEquity and its subsidiaries administer HSAs and other consumer-directed benefits for its more than 12 million accounts in partnership with employers, benefits advisors, and health and retirement plan providers who

HQY's quick ratio has surged by 102% year-on-year and by 6% since the previous quarter

The equity has grown by 39% YoY

HQY's net income has surged by 104% year-on-year but it has dropped by 84% since the previous quarter

HQY's EPS has surged by 103% year-on-year but it has dropped by 83% since the previous quarter

The P/E is 131% higher than the last 4 quarters average of 2769.2

What are the main financial stats of HQY

Market
Valuations
Earnings

Shares outstanding

83.51M

Market cap

$5.35B

Enterprise value

$5.65B

Price to earnings (P/E)

6,406

Price to book (P/B)

2.87

Price to sales (P/S)

7.22

EV/EBIT

340.47

EV/EBITDA

40.03

EV/Sales

7.63

Revenue

$740.83M

EBIT

$16.6M

EBITDA

$141.22M

Free cash flow

$108.86M

Per share
Balance sheet
Liquidity

EPS

$0.01

Free cash flow per share

$1.3

Book value per share

$22.34

Revenue per share

$8.87

TBVPS

$12.16

Total assets

$3.15B

Total liabilities

$1.29B

Debt

$1.06B

Equity

$1.86B

Working capital

$675.49M

Debt to equity

0.57

Current ratio

4.65

Quick ratio

4.47

Net debt/EBITDA

2.14

Margins
Efficiency
Dividend

EBITDA margin

19.1%

Gross margin

56.8%

Net margin

0.1%

Operating margin

1.8%

Return on assets

0%

Return on equity

0%

Return on invested capital

1.4%

Return on capital employed

0.6%

Return on sales

2.2%

Dividend yield

N/A

DPS

N/A

Payout ratio

N/A

How has the Healthequity stock price performed over time

Intraday

3.61%

1 week

0.42%

1 month

3.57%

1 year

26.85%

YTD

-8.11%

QTD

-20.4%

How have Healthequity's revenue and profit performed over time

Revenue

$740.83M

Gross profit

$420.56M

Operating income

$13.29M

Net income

$723,000

Gross margin

56.8%

Net margin

0.1%

The net margin has surged by 104% year-on-year but it has dropped by 83% since the previous quarter

HQY's net income has surged by 104% year-on-year but it has dropped by 84% since the previous quarter

HQY's operating income has dropped by 73% year-on-year and by 43% since the previous quarter

Healthequity's operating margin has plunged by 73% YoY and by 44% from the previous quarter

What is Healthequity's growth rate over time

What is Healthequity stock price valuation

P/E

6,406

P/B

2.87

P/S

7.22

EV/EBIT

340.47

EV/EBITDA

40.03

EV/Sales

7.63

The P/E is 131% higher than the last 4 quarters average of 2769.2

HQY's EPS has surged by 103% year-on-year but it has dropped by 83% since the previous quarter

The stock's P/B is 58% below its 5-year quarterly average of 6.9 and 20% below its last 4 quarters average of 3.6

The equity has grown by 39% YoY

The stock's price to sales (P/S) is 40% less than its 5-year quarterly average of 12.1 and 6% less than its last 4 quarters average of 7.7

HQY's revenue is up by 2.3% year-on-year

How efficient is Healthequity business performance

The ROE has plunged by 100% from the previous quarter but it has soared by 100% YoY

The ROA has plunged by 100% from the previous quarter but it has soared by 100% YoY

HQY's return on sales is down by 37% since the previous quarter but it is up by 4.8% year-on-year

HQY's ROIC is down by 33% QoQ but it is up by 27% YoY

What is HQY's dividend

DPS

N/A

Dividend yield

N/A

Payout ratio

N/A

There are no recent dividends present for HQY.

How did Healthequity financials performed over time

Healthequity's total assets is 145% higher than its total liabilities

HQY's quick ratio has surged by 102% year-on-year and by 6% since the previous quarter

Healthequity's current ratio has surged by 87% YoY and by 3.3% QoQ

The debt is 43% smaller than the equity

The equity has grown by 39% YoY

The debt to equity has declined by 30% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.